The roles and therapeutic approaches of MSC-derived exosomes in colorectal cancer Jie YangLiman Zhang Review Article 17 January 2022 Pages: 959 - 967
A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper N. ZozayaJ. VillasecaA. Hidalgo-Vega Review Article Open access 08 January 2022 Pages: 968 - 980
Current status and future perspectives in HER2 positive advanced gastric cancer G. RovielloM. CatalanoL. Antonuzzo Review Article 29 January 2022 Pages: 981 - 996
Long non-coding RNAs involved in different steps of cancer metastasis P. SumanY. ChhichholiyaA. Munshi Review Article 04 February 2022 Pages: 997 - 1013
Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma L. K. KadianM. AroraS. S. Chauhan Review Article 06 January 2022 Pages: 1014 - 1032
Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer M. D. Torregrosa-MaicasS. del Barco-BerrónR. Gironés-Sarrió Special Article Open access 01 February 2022 Pages: 1033 - 1046
A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance M. T. A. StrousT. K. E. FaesA. P. de Bruïne Research Article 22 January 2022 Pages: 1047 - 1058
The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway B. LiS. PangY. Zhou Research Article 23 January 2022 Pages: 1059 - 1072
IFN-γ affects pancreatic cancer properties by MACC1-AS1/MACC1 axis via AKT/mTOR signaling pathway X.-Y. ShiX.-L. ZhangS.-Y. Qin Research Article 17 January 2022 Pages: 1073 - 1085
Roles of circ_0000135/miR-140-3p/PDZK1 network in cervical cancer N. WangY. ZhengJ. Q. Liu Research Article 23 January 2022 Pages: 1086 - 1099
Identification of immunophenotypes in esophageal squamous cell carcinoma based on immune gene sets Danlei SongYongjian WeiYongning Zhou Research Article 31 January 2022 Pages: 1100 - 1114
MicroRNA-4463 facilitates the development of colon cancer by suppression of the expression of PPP1R12B J. TanT. LuY. Zhu Research Article 22 January 2022 Pages: 1115 - 1123
LncRNA ABHD11-AS1 promotes tumor progression in papillary thyroid carcinoma by regulating EPS15L1/EGFR signaling pathway H. LuC. ZhuQ. Wei Research Article 31 January 2022 Pages: 1124 - 1133
Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy people Ningning LiChunmei BaiXiaoyuan Li Research Article 15 February 2022 Pages: 1134 - 1147
Negative value of CD10−/CD34− immunophenotype in pediatric leukemia and development of a related cell line model for investigating drug resistance N. AberuyiS. Rahgozar Research Article 05 January 2022 Pages: 1148 - 1156
The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression P. A. BousquetS. MeltzerA. H. Ree Research Article Open access 27 December 2021 Pages: 1157 - 1167
DAZAP1 overexpression promotes growth of HCC cell lines: a primary study using CEUS J. J. DengG. P. LiY. Wang Research Article 29 January 2022 Pages: 1168 - 1176
Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis F. DeodatoD. PezzullaG. Macchia Research Article 04 January 2022 Pages: 1177 - 1183
Circulating myeloid-derived suppressors cells correlate with clinicopathological characteristics and outcomes undergoing neoadjuvant chemoimmunotherapy in non-small cell lung cancer T. WenC. SuZ. Liu Research Article 06 January 2022 Pages: 1184 - 1194
circRNA CRIM1 regulates the migration and invasion of bladder cancer by targeting miR182/Foxo3a axis X. Y. YuC. Q. MaY. H. Sheng Research Article 07 January 2022 Pages: 1195 - 1203
Pediatric medulloblastoma express immune checkpoint B7-H3 S. LiG. C. PoolenN. Bovenschen Brief Research Article Open access 05 January 2022 Pages: 1204 - 1208
Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer A. Fernández MontesE. ÉlezE. Aranda Brief Research Article Open access 07 January 2022 Pages: 1209 - 1214
Letter to the editor regarding ‘Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY‑2 clinical trial subanalysis’ Cem OnalEzgi Oymak Correspondence 03 March 2022 Pages: 1215 - 1216
Reply to “Letter to the editor regarding ‘Stereotactic radiosurgery for bone metastases in oligometastatic prostate cancer patients: DESTROY-2 clinical trial subanalysis’” Francesco DeodatoDonato PezzullaGabriella Macchia Correspondence 19 March 2022 Pages: 1217 - 1218